These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 39307909)

  • 21. [Novel treatment strategies for acquired hemophilia A].
    Higasa S
    Rinsho Ketsueki; 2024; 65(6):560-566. PubMed ID: 38960657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A.
    Collins P; Baudo F; Huth-Kühne A; Ingerslev J; Kessler CM; Castellano ME; Shima M; St-Louis J; Lévesque H
    BMC Res Notes; 2010 Jun; 3():161. PubMed ID: 20529258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppression Therapy in Acquired Hemophilia A: Pursuing an Optimal Regimen.
    Teixeira Passos D; Abrantes AM; Santos L; Cardoso A; Pais de Lacerda A
    Cureus; 2021 Dec; 13(12):e20467. PubMed ID: 35047291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group.
    Pfrepper C; Klamroth R; Oldenburg J; Holstein K; Eichler H; Hart C; Moehnle P; Schilling K; Trautmann-Grill K; Alrifai M; Ay C; Miesbach W; Knoebl P; Tiede A
    Hamostaseologie; 2023 Dec; ():. PubMed ID: 38049124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and Management of Acquired Hemophilia A: Case Reports and a Literature Review.
    Rinaldi I; Prasetyawaty F; Fazlines S; Winston K; Samudera Nurrobi YA; Leoni J; Restu Tulus Maha IH; Wicaksono S; Wicaksono AY; Aslani AO; Ikhsani R
    Case Rep Med; 2021; 2021():5554664. PubMed ID: 34567128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A Pediatric Case of Acquired Hemophilia A: The Usefulness of the Activated Partial Thromboplastin Time (APTT) Cross-Mixing Test for Early Diagnosis].
    Asai H; Shirayama R; Oshida K; Honda Y; Sato T; Sakai M; Kusuhara K
    J UOEH; 2018; 40(4):331-337. PubMed ID: 30568085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired Hemophilia A and urothelial carcinoma.
    Taza F; Suleman N; Paz R; Haas C
    J Community Hosp Intern Med Perspect; 2021 Jan; 11(1):89-93. PubMed ID: 33552425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired haemophilia: an overview for clinical practice.
    Kessler CM; Knöbl P
    Eur J Haematol; 2015 Dec; 95 Suppl 81():36-44. PubMed ID: 26679396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
    Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
    J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acquired hemophilia A].
    Tokugawa T
    Rinsho Ketsueki; 2020; 61(7):785-790. PubMed ID: 32759566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort.
    Ellsworth P; Chen SL; Kasthuri RS; Key NS; Mooberry MJ; Ma AD
    Blood Adv; 2020 Dec; 4(24):6240-6249. PubMed ID: 33351122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
    Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
    Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.
    Huth-Kühne A; Baudo F; Collins P; Ingerslev J; Kessler CM; Lévesque H; Castellano ME; Shima M; St-Louis J
    Haematologica; 2009 Apr; 94(4):566-75. PubMed ID: 19336751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired haemophilia A: a 2013 update.
    Franchini M; Mannucci PM
    Thromb Haemost; 2013 Dec; 110(6):1114-20. PubMed ID: 24008306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitor eradication and treatment for acquired hemophilia A.
    Franchini M; Focosi D
    Expert Rev Hematol; 2024 Jun; 17(6):233-240. PubMed ID: 38708599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Severe Acquired Haemophilia A with Immunosuppressive Agent: A Case Report of One Patient.
    Škunca Ž; Peraica AP
    Coll Antropol; 2016 Jun; 40(2):139-43. PubMed ID: 29139630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acquired haemophilia (acquired factor VIII inhibitor)].
    Ceresetto JM; Duboscq C; Fondevila C; Tezanos Pinto M
    Medicina (B Aires); 2015; 75(4):231-8. PubMed ID: 26339881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Life-threatening hemorrhage from acquired hemophilia A as a presenting manifestation of prostate cancer.
    Sheth C; Gill A; Sekhon S
    J Community Hosp Intern Med Perspect; 2016; 6(4):32461. PubMed ID: 27609734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired haemophilia syndrome: pathophysiology and therapy.
    Elezović I
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
    Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
    Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.